4X80
Crystal Structure of murine 7B4 Fab monoclonal antibody against ADAMTS5
4X80 の概要
エントリーDOI | 10.2210/pdb4x80/pdb |
関連するPDBエントリー | 4X8J |
分子名称 | IgG1 7B4 FAB Light Chain, IgG1 7B4 FAB Heavy chain (3 entities in total) |
機能のキーワード | monoclonal, immune system |
由来する生物種 | Mus musculus 詳細 |
タンパク質・核酸の鎖数 | 2 |
化学式量合計 | 47693.81 |
構造登録者 | Larkin, J.,Lohr, T.A.,Elefante, L.,Shearin, J.,Matico, R.,Su, J.-L.,Xue, Y.,Liu, F.,Genell, C.,Miller, R.E.,Tran, P.B.,Malfait, A.-M.,Maier, C.C.,Matheny, C.J. (登録日: 2014-12-09, 公開日: 2015-04-08, 最終更新日: 2015-08-05) |
主引用文献 | Larkin, J.,Lohr, T.A.,Elefante, L.,Shearin, J.,Matico, R.,Su, J.L.,Xue, Y.,Liu, F.,Genell, C.,Miller, R.E.,Tran, P.B.,Malfait, A.M.,Maier, C.C.,Matheny, C.J. Translational development of an ADAMTS-5 antibody for osteoarthritis disease modification. Osteoarthr. Cartil., 23:1254-1266, 2015 Cited by PubMed Abstract: Aggrecanase activity, most notably ADAMTS-5, is implicated in pathogenic cartilage degradation. Selective monoclonal antibodies (mAbs) to both ADAMTS-5 and ADAMTS-4 were generated and in vitro, ex vivo and in vivo systems were utilized to assess target engagement, aggrecanase inhibition and modulation of disease-related endpoints with the intent of selecting a candidate for clinical development in osteoarthritis (OA). PubMed: 25800415DOI: 10.1016/j.joca.2015.02.778 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.6 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード